Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Incyte's JAK cream Opzelura slows while Leo competition looms
Leo Pharma's delgocitinib could shake up the topical JAK market and put pressure on Incyte's approved Opzelura.
Zoey Becker
May 3, 2024 10:53am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Sponsored
ADVI Experts Discuss the Future of the Inflation Reduction Act
Apr 29, 2024 8:00am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
Sponsored
Collaborative partnerships key to clearing the path for new biopharma products
Apr 29, 2024 8:00am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am